MAPT and Alzheimer disease: Sonawane and Chinnathambi showed that upregulating the GS3K-β promoter by demethylation and downregulating the PP2A promoter by methylation accelerated Tau hyperphosphorylation, thus increasing the risk of AD (Sonawane and Chinnathambi, 2018).